Temozolomide for adult brain stem glioblastoma: case report of a long-term survivor

Int J Neurosci. 2010 Dec;120(12):787-91. doi: 10.3109/00207454.2010.520377. Epub 2010 Oct 15.

Abstract

Brain stem gliomas are rare intracranial tumors, especially in adults. Malignant or high-grade brain stem gliomas are usually associated with a very poor prognosis. This case report documents an adolescent harboring brain stem glioblastoma who had complete radiological response to temozolomide after partial tumor resection and survived for more than 3 years. Radiological and pathological findings are described. To the best of our knowledge, no similar cases have been reported in the literature.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage*
  • Brain Stem Neoplasms / drug therapy*
  • Brain Stem Neoplasms / mortality*
  • Brain Stem Neoplasms / surgery
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives*
  • Fatal Outcome
  • Glioblastoma / drug therapy*
  • Glioblastoma / mortality*
  • Glioblastoma / surgery
  • Humans
  • Male
  • Survival Rate / trends
  • Temozolomide
  • Treatment Outcome
  • Young Adult

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide